Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

(S)he said what!?
At the ADA meeting. Biodel, Latitude, and Xeris had notable announcements on their glucagon programs. First, Biodel demonstrated a prototype of its new glucagon rescue...
(S)he said what!?
On July 31, the ADA issued a statement on the importance of accurate blood glucose meters and test strips, calling for the FDA to continually monitor product quality and...
Newly diagnosed with type 1 diabetes? The top ten things you should know!
Last month, the Fight4MyFeet campaign launched to increase awareness of diabetic foot ulcers among people with diabetes, including a host of valuable tips on how to...
An open letter to the FDA’s Dr. Margaret Hamburg from diaTribe .
MediSafe is a free mobile app (Android and iPhone) designed to help people integrate their medications into daily life. Patients can enter their medications into the app...
In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.
On January 20, Tandem announced an expanded recall on its t:slim insulin pump cartridges – the affected cartridges ( listed here ) may be at risk of insulin leaking...
The 73rd Scientific Sessions of the American Diabetes Association will be held from June 21-25 in Chicago. The five-day conference will feature hundreds of presentations...
(S)he said what!?
On October 3, Orexigen announced that it submitted Contrave (naltrexone/bupropion) to the European Medicine Agency for weight loss management. Assuming a successful...
On February 19, Abbott announced a recall of FreeStyle and FreeStyle Flash blood glucose meters, which may produce low blood sugar results incorrectly when used with...
Where are we on the road to curing type 1 diabetes? Read about our eBook with the American Diabetes Association, with great inspiration from JDRF and the Helmsley...
On June 18, the American Medical Association (AMA) officially adopted policy recognizing obesity as a disease. Although the decision does not have legal force, some...
At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.
Diabetic peripheral neuropathy (DPN) is a complication that will affect about 60-70% of all people who have diabetes at some point in their lifetime. DPN causes reduced...
A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.
On December 9, Sanofi launched the second Partners in Patient Health (PIPH) Innovation Challenge on “Co-Creating for Breakthroughs: Moving toward a collaborative...

Pages